(Q39821064)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21046212%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Effects of caffeic acid phenethyl ester (CAPE) on hepatopulmonary syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21046212%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21046212%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Ahmet Tekin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21046212%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Serdar Türkyılmaz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21046212%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Tevfik Küçükkartallar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21046212%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Murat Cakır

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21046212%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Hüseyin Yılmaz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21046212%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Hasan Esen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21046212%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Ilhan Ciftci

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21046212%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Adil Kartal

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21046212%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21046212%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21046212%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21046212%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21046212%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

614-619

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21046212%20AND%20SRC:MED&resulttype=core&format=json

Hepatopulmonary syndrome. A pulmonary vascular complication of liver disease

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9270-8

Exercise-aggravated hypoxemia and orthodeoxia in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9270-8

Pulmonary-Hepatic vascular Disorders (PHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9270-8

Pulmonary vascular disorders in portal hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9270-8

Effects of caffeic acid phenethyl ester on pancreatitis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9270-8

Caffeic acid phenethyl ester inhibits nitric oxide synthase gene expression and enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9270-8

Protective effect of caffeic acid phenethyl ester (CAPE) on lipid peroxidation and antioxidant enzymes in diabetic rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9270-8

Effects of caffeic acid phenethyl ester on glycerol-induced acute renal failure in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9270-8

Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9270-8

Deleterious effect of nitric oxide inhibition in chronic hepatopulmonary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9270-8

Hepatopulmonary syndrome. Current concepts in diagnostic and therapeutic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9270-8

Lithium-induced lung toxicity in rats: the effect of caffeic acid phenethyl ester (CAPE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9270-8

Suppression of adenovirus type 5 E1A-mediated transformation and expression of the transformed phenotype by caffeic acid phenethyl ester (CAPE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9270-8

Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin-induced nephrotoxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9270-8

Protective role of caffeic acid phenethyl ester (cape) on gentamicin-induced acute renal toxicity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9270-8

Structural and pathologic changes in the lung vasculature in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9270-8

The hepatopulmonary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9270-8

The Incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9270-8

Caffeic acid phenethyl ester decreases acute pneumonitis after irradiation in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-010-9270-8

Hepatopulmonary syndrome: is NO the right answer?

21 January 2018

1 reference

12 December 2020

Inhibition of K(Ca) channels restores blunted hypoxic pulmonary vasoconstriction in rats with cirrhosis

1 reference

12 December 2020

The hepatopulmonary syndrome

1 reference

12 December 2020

Pulmonary circulatory dysfunction in rats with biliary cirrhosis. An animal model of the hepatopulmonary syndrome

1 reference

12 December 2020

Endothelin-1 in the rat bile duct ligation model of hepatopulmonary syndrome: correlation with pulmonary dysfunction

1 reference

12 December 2020

The effects of serum estrogen levels on hypoxemia and blood nitric oxide levels in experimental hepatopulmonary syndrome

1 reference

12 December 2020

Endothelium-derived relaxing factor in pulmonary and renal circulations during hypoxia

1 reference

12 December 2020

Common bile duct ligation in the rat: a model of intrapulmonary vasodilatation and hepatopulmonary syndrome

1 reference

12 December 2020

Role of NO in the pulmonary artery hyporeactivity to phenylephrine in experimental biliary cirrhosis

1 reference

12 December 2020

Mechanisms of pulmonary vascular complications of liver disease: hepatopulmonary syndrome

1 reference

12 December 2020

Caffeic acid phenethyl ester (CAPE) protects rat skeletal muscle against ischemia-reperfusion-induced oxidative stress

1 reference

12 December 2020

Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis

1 reference

12 December 2020

Endothelin-1 stimulation of endothelial nitric oxide synthase in the pathogenesis of hepatopulmonary syndrome

1 reference

12 December 2020

Hyperdynamic circulation in cirrhosis: a role for nitric oxide?

1 reference

12 December 2020